The Liver Meeting 2020-2020 Hepatitis Debrief

Video Transcription

Video Summary

Nancy Rowe from Rush University Medical Center provided a detailed debrief of the 2020 Liver Meeting Viral Hepatitis research. Key topics included Hepatitis C, where strategies for screening, treatment, and modeling scenarios were discussed. Studies on new treatments like the MIN-MAN trial with a simplified approach were highlighted. The HERO study focused on treating Hepatitis C in people who inject drugs. In Hepatitis B research, studies on antiviral therapy withdrawal and functional cure approaches were presented. Exciting therapeutic developments such as CRISPR-Cas9 targeting the Hepatitis B genome were discussed. Studies on Hepatitis B surface antigen reduction, such as with AB729 and ALG133, were showcased. The conference also covered Hepatitis Delta research, including the LIFT-HD study on pegylated lambda combination therapy. Overall, the debrief emphasized the importance of innovative research and treatment strategies in combating viral hepatitis.

Keywords

Liver Meeting

Viral Hepatitis research

Hepatitis C

Hepatitis B

MIN-MAN trial

HERO study

CRISPR-Cas9